Advertisement

European Journal of Clinical Pharmacology

, Volume 75, Issue 10, pp 1459–1466 | Cite as

2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors

  • Encarnación Blanco-ReinaEmail author
  • Jenifer Valdellós
  • Lorena Aguilar-Cano
  • Maria Rosa García-Merino
  • Ricardo Ocaña-Riola
  • Gabriel Ariza-Zafra
  • Inmaculada Bellido-Estévez
Pharmacoepidemiology and Prescription

Abstract

Purpose

To comparatively assess the prevalence rates of potentially inappropriate medications (PIMs) obtained by the former and latest versions of American Geriatrics Society Beers Criteria (AGS BC) and screening tool of older person’s potentially inappropriate prescriptions (STOPP), and analyze the factors of influence on PIM.

Methods

Cross-sectional study including 582 community-dwelling older adults over the age of 65. Sociodemographic, clinical, functional, and comprehensive drug therapy data were collected. The primary endpoint was the percentage of patients receiving at least one PIM.

Results

A total of 3626 prescriptions were analyzed. PIMs were detected in 35.4% and 47.9% of patients according to the STOPP v1 and the 2012 AGS BC, respectively. This percentage rose to 54% when 2015 AGS BC were used and reached 66.8% with STOPP v2. The kappa coefficient between STOPP v2 and its former version was lower than the one between the updated Beers Criteria and their former version (0.41 vs 0.85). The agreement was good (0.65) between both latest criteria. The number of medications, psychological disorders, and insomnia were predictors of PIM. A novel finding was that bone and joint disorders increased the odds for PIM by 78%.

Conclusions

The 2015 AGS BC showed high sensitivity and good applicability to the European older patients. Both updated tools identified some pharmacological groups (benzodiazepines, PPIs, and opioids, among others) and certain health problems (insomnia, psychological disorders, and osteoarticular diseases) as factors of influence on PIM. Based on these findings, interventions aimed at promoting appropriate use of medications should be developed.

Keywords

Potentially inappropriate medications STOPP version 2 Beers Criteria Older adults 

Notes

Acknowledgments

The authors wish to thank the Primary Care Management Team (Health District of Málaga) for providing access to the health centers and patient lists.

Author contributions

Study concept and design: EBR, GAZ. Data collection: JV, LAC, MRGM. Data analysis: EBR, ROR. Interpretation: EBR, GAZ, IBE, ROR, JV, LAC, MRGM. Drafting of the manuscript: EBR, IBE. Revision and final approval: EBR, JV, LAC, MRGM, ROR, IBE, GAZ. Funding acquisition: EBR.

Funding

This research has been supported by grant funding provided by the Fundación Pública Andaluza Progreso y Salud, Consejería de Salud, Junta de Andalucía, through the Programme Proyectos de Investigación Biomédica (Grant number PI 0234/14).

Compliance with ethical standards

The study has been approved by the Clinical Research Ethics Committee of Málaga and is being conducted in accordance with the 1964 Helsinki declaration and its later amendments. Written informed consent was obtained from all individual participants prior to their inclusion.

Conflict of interest

All authors declare that they have no conflict of interest.

Supplementary material

228_2019_2722_MOESM1_ESM.docx (27 kb)
ESM 1 (DOCX 27 kb)

References

  1. 1.
    Cahir C, Bennett K, Teljeur C, FAhey T (2014) Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol 77(1):201–210CrossRefGoogle Scholar
  2. 2.
    Bradley MC, Fahey T, Cahir C, Bennett K, O’Reilly D, Parsons C, Hughes CM (2012) Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland enhanced prescribing database. Eur J Clin Pharmacol 68(10):1425–1433CrossRefGoogle Scholar
  3. 3.
    Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171(11):1013–1019CrossRefGoogle Scholar
  4. 4.
    Hagstrom K, Nailor M, Lindberg M, Hobbs L, Sobieraj DM (2015) Association between potentially inappropriate medication use in elderly adults and hospital-related outcomes. J Am Geriatr Soc 63(1):185–186CrossRefGoogle Scholar
  5. 5.
    Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Petzold M, Hägg S (2015) Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol 71(12):1525–1533CrossRefGoogle Scholar
  6. 6.
    Price SD, Holman CD, Sanfilippo FM, Emery JD (2014) Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother 48(1):6–16CrossRefGoogle Scholar
  7. 7.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832CrossRefGoogle Scholar
  8. 8.
    Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 157(14):1531–1536CrossRefGoogle Scholar
  9. 9.
    The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616–631CrossRefGoogle Scholar
  10. 10.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (screening tool of older persons’ prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72–83CrossRefGoogle Scholar
  11. 11.
    Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, Mádlová P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O’Mahony D (2011) Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 67(11):1175–1188CrossRefGoogle Scholar
  12. 12.
    O'Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2014) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218CrossRefGoogle Scholar
  13. 13.
    The American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246CrossRefGoogle Scholar
  14. 14.
    Steinman MA, Beizer JL, DuBeau CE, Laird RD, Lundebjerg NE, Mulhausen P (2015) How to use the American Geriatrics Society 2015 Beers Criteria-a guide for patients, clinicians, health systems, and payors. J Am Geriatr Soc 63(12):e1–e7CrossRefGoogle Scholar
  15. 15.
    Hanlon JT, Semla TP, Schmader KE (2015) Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc 63(12):e8–e18CrossRefGoogle Scholar
  16. 16.
    Barenholtz Levy H, Marcus EL (2016) Potentially inappropriate medications in older adults: why the revised criteria matter. Ann Pharmacother 50(7):599–603CrossRefGoogle Scholar
  17. 17.
    Skaar DD, O’Connor H (2017) Using the Beers criteria to identify potentially inappropriate medication use by older adult dental patients. J Am Dent Assoc 148(5):298–307CrossRefGoogle Scholar
  18. 18.
    Extavour RM, Perri M 3rd (2018) Patient, physician, and health-system factors influencing the quality of antidepressant and sedative prescribing for older, community-dwelling adults. Health Serv Res 53(1):405–429CrossRefGoogle Scholar
  19. 19.
    Novaes PH, da Cruz DT, Lucchetti ALG, Leite ICG, Lucchetti G (2017) Comparison of four criteria for potentially inappropriate medications in Brazilian community-dwelling older adults. Geriatr Gerontol Int 17(10):1628–1635Google Scholar
  20. 20.
    Reis CM, Dos Santos AG, de Jesus Souza P, Reis AMM (2017) Factors associated with the use of potentially inappropriate medications by older adults with cancer. J Geriatr Oncol 8(4):303–307CrossRefGoogle Scholar
  21. 21.
    Suehs BT, Davis C, Ng DB, Gooch K (2017) Impact of 2015 update to the Beers criteria on estimates of prevalence and costs associated with potentially inappropriate use of antimuscarinics for overactive bladder. Drugs Aging 34(7):535–543CrossRefGoogle Scholar
  22. 22.
    Sheikh-Taha M, Dimassi H (2017) Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovasc Disord 17(1):189CrossRefGoogle Scholar
  23. 23.
    Bala SS, Narayan SW, Nishtala PS (2018) Potentially inappropriate medications in community-dwelling older adults undertaken as a comprehensive geriatric risk assessment. Eur J Clin Pharmacol 74(5):645–653CrossRefGoogle Scholar
  24. 24.
    Muhlack DC, Hoppe LK, Stock C, Haefeli WE, Brenner H, Schöttker B (2018) The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study. Eur J Clin Pharmacol 74(12):1633–1644CrossRefGoogle Scholar
  25. 25.
    Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, León-Ortiz M (2014) 2012 American Geriatrics Society Beers Criteria: enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the screening tool of older person’s potentially inappropriate prescriptions. J Am Geriatr Soc 62(7):1217–1223CrossRefGoogle Scholar
  26. 26.
    Bahat G, Bay I, Tufan A, Tufan F, Kilic C, Karan MA (2017) Prevalence of potentially inappropriate prescribing among older adults: a comparison of the Beers 2012 and screening tool of older person’s prescriptions criteria version 2. Geriatr Gerontol Int 17(9):1245–1251CrossRefGoogle Scholar
  27. 27.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefGoogle Scholar
  28. 28.
    Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919CrossRefGoogle Scholar
  29. 29.
    Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186CrossRefGoogle Scholar
  30. 30.
    Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23(10):433–441CrossRefGoogle Scholar
  31. 31.
    Sheikh JI, Yesavage JA (1986) Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 5:165–173CrossRefGoogle Scholar
  32. 32.
    Hosmer D, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley, New JerseyCrossRefGoogle Scholar
  33. 33.
    Fox J, Monette G (1998) Generalized collinearity diagnostics. J Am Stat Assoc 87:178–183CrossRefGoogle Scholar
  34. 34.
    Santos AP, da Silva DT, dos Santos Júnior GA, Silvestre CC, Nunes MA, Lyra DP Jr, Antoniolli AR (2015) Evaluation of the heterogeneity of studies estimating the association between risk factors and the use of potentially inappropriate drug therapy for the elderly: a systematic review with meta-analysis. Eur J Clin Pharmacol 71(9):1037–1050CrossRefGoogle Scholar
  35. 35.
    Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K (2015) Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 71(12):1415–1427CrossRefGoogle Scholar
  36. 36.
    Bruin-Huisman L, Abu-Hanna A, van Weert HCPM, Beers E (2017) Potentially inappropriate prescribing to older patients in primary care in the Netherlands: a retrospective longitudinal study. Age Ageing 46(4):614–619Google Scholar
  37. 37.
    Di Giorgio C, Provenzani A, Polidori P (2016) Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria. Int J Clin Pharm 38(2):462–468CrossRefGoogle Scholar
  38. 38.
    Brown JD, Hutchison LC, Li C, Painter JT, Martin BC (2016) Predictive validity of the Beers and screening tool of older persons’ potentially inappropriate prescriptions (STOPP) criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. J Am Geriatr Soc 64(1):22–30CrossRefGoogle Scholar
  39. 39.
    Mucalo I, Hadžiabdić MO, Brajković A, Lukić S, Marić P, Marinović I, Bačić-Vrca V (2017) Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol 73(8):991–999CrossRefGoogle Scholar
  40. 40.
    Hudhra K, Beçi E, Petrela E, Xhafaj D, García-Caballos M, Bueno-Cavanillas A (2016) Prevalence and factors associated with potentially inappropriate prescriptions among older patients at hospital discharge. J Eval Clin Pract 22(5):707–713CrossRefGoogle Scholar
  41. 41.
    Lucchetti G, Lucchetti AL (2017) Inappropriate prescribing in older persons: a systematic review of medications available in different criteria. Arch Gerontol Geriatr 68:55–61CrossRefGoogle Scholar
  42. 42.
    Khong TP, de Vries F, Goldenberg JS, Klungel OH, Robinson NJ, Ibáñez L, Petri H (2012) Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int 91(1):24–31CrossRefGoogle Scholar
  43. 43.
    Airagnes G, Pelissolo A, Lavallée M, Flament M, Limosin F (2016) Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep 18(10):89CrossRefGoogle Scholar
  44. 44.
    Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D (2017) A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol 73(8):927–935CrossRefGoogle Scholar
  45. 45.
    Moriarty F, Bennett K, Cahir C, Fahey T (2016) Characterizing potentially inappropriate prescribing of proton pump inhibitors in older people in primary care in Ireland from 1997 to 2012. J Am Geriatr Soc 64(12):e291–e296CrossRefGoogle Scholar
  46. 46.
    Haastrup P, Paulsen MS, Begtrup LM, Hansen JM, Jarbøl DE (2014) Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract 31(6):625–630CrossRefGoogle Scholar
  47. 47.
    Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T (2015) Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 5(9):e008656CrossRefGoogle Scholar
  48. 48.
    Lönnbro J, Wallerstedt SM (2017) Clinical relevance of the STOPP/START criteria in hip fracture patients. Eur J Clin Pharmacol 73(4):499–505CrossRefGoogle Scholar
  49. 49.
    Lang PO, Petrovic M, Dalleur O, Ferahta N, Benetos A, Boland B (2016) The exercise in applying STOPP/START.v2 in vulnerable very old patients: towards patient tailored prescribing. Eur Geriatr Med 7(2):1176–1179CrossRefGoogle Scholar
  50. 50.
    Tan ECK, Sluggett JK, Johnell K, Onder G, Elseviers M, Morin L, Vetrano DL, Wastesson JW, Fastbom J, Taipale H, Tanskanen A, Bell JS, (Optimizing Geriatric Pharmacotherapy through Pharmacoepidemiology Network –OPPEN- Group) (2018) Research priorities for optimizing geriatric pharmacotherapy: an international consensus. J Am Med Dir Assoc 19(3):193–199CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Encarnación Blanco-Reina
    • 1
    Email author
  • Jenifer Valdellós
    • 2
  • Lorena Aguilar-Cano
    • 3
  • Maria Rosa García-Merino
    • 4
  • Ricardo Ocaña-Riola
    • 5
  • Gabriel Ariza-Zafra
    • 6
  • Inmaculada Bellido-Estévez
    • 1
  1. 1.Pharmacology and Therapeutics Department, School of Medicine, Instituto de Investigación Biomédica de Málaga-IBIMAUniversity of MálagaMálagaSpain
  2. 2.Health District of Málaga-GuadalhorceMálagaSpain
  3. 3.Health District of MálagaMálagaSpain
  4. 4.Health District of Córdoba SurCórdobaSpain
  5. 5.Andalusian School of Public HealthGranadaSpain
  6. 6.Geriatrics DepartmentComplejo Hospitalario Universitario de AlbaceteAlbaceteSpain

Personalised recommendations